Iio, Etsuko
Matsuura, Kentaro
Shimada, Noritomo
Atsukawa, Masanori
Itokawa, Norio
Abe, Hiroshi
Kato, Keizo
Takaguchi, Koichi
Senoh, Tomonori
Eguchi, Yuichiro
Nomura, Hideyuki
Yoshizawa, Kai
Kang, Jong-Hon
Matsui, Takeshi
Hirashima, Noboru
Kusakabe, Atsunori
Miyaki, Tomokatsu
Fujiwara, Kei
Matsunami, Kayoko
Tsutsumi, Susumu
Iwakiri, Katsuhiko
Tanaka, Yasuhito
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP18fk0210001h0003)
Japan Society for the Promotion of Science (17K15960)
Article History
Received: 29 August 2018
Accepted: 24 October 2018
First Online: 31 October 2018
Compliance with ethical standards
:
: Yasuhito Tanaka is currently conducting research sponsored by Chugai Pharmaceutical Co., Ltd and has received honoraria from Janssen Pharmaceutical K.K, and Gilead Sciences. Masanori Atsukawa is currently conducting research sponsored by MSD K.K., and AbbVie Inc., and has received honoraria from MSD K.K. and Gilead Sciences. Koichi Takaguchi has received honoraria from Gilead Sciences, MSD K.K., AbbVie Inc., Bristol-Myers Squibb, and Astrazeneka KK. Hideyuki Nomura has received honoraria from Gilead Sciences. The other authors declare no conflicts of interest.